Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02529553
Title A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications

urinary bladder cancer

Advanced Solid Tumor

Therapies

LY3076226

Age Groups: adult
Covered Countries USA | CAN

Additional content available in CKB BOOST